Gotch F - Search Results

1

Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates.

Spentzou A, Bergin P, Gill D, Cheeseman H, Ashraf A, Kaltsidis H, Cashin-Cox M, Anjarwalla I, Steel A, Higgs C, Pozniak A, Piechocka-Trocha A, Wong J, Anzala O, Karita E, Dally L, Gotch F, Walker B, Gilmour J, Hayes P. Spentzou A, et al. Among authors: gotch f. J Infect Dis. 2010 Mar;201(5):720-9. doi: 10.1086/650492. J Infect Dis. 2010. PMID: 20132004

2

Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials.

Kaltsidis H, Cheeseman H, Kopycinski J, Ashraf A, Cox MC, Clark L, Anjarwalla I, Dally L, Bergin P, Spentzou A, Higgs C, Gotch F, Gazzard B, Gomez R, Hayes P, Kelleher P, Gill DK, Gilmour J. Kaltsidis H, et al. Among authors: gotch f. J Immunol Methods. 2011 Jul 29;370(1-2):43-54. doi: 10.1016/j.jim.2011.05.007. Epub 2011 Jun 12. J Immunol Methods. 2011. PMID: 21669205 Clinical Trial.

3

Elevated mucosal addressin cell adhesion molecule-1 expression in acquired immunodeficiency syndrome is maintained during antiretroviral therapy by intestinal pathogens and coincides with increased duodenal CD4 T cell densities.

Miao YM, Hayes PJ, Gotch FM, Barrett MC, Francis ND, Gazzard BG. Miao YM, et al. J Infect Dis. 2002 Apr 15;185(8):1043-50. doi: 10.1086/340235. Epub 2002 Apr 1. J Infect Dis. 2002. PMID: 11930313

4

HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.

Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P. Steel A, et al. Antivir Ther. 2007;12(6):971-5. Antivir Ther. 2007. PMID: 17926652

5

Science, medicine and research in the developing world: a perspective.

Gotch F, Gilmour J. Gotch F, et al. Nat Immunol. 2007 Dec;8(12):1273-6. doi: 10.1038/ni1531. Nat Immunol. 2007. PMID: 17952077 No abstract available.

6

CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.

Steel A, John L, Shamji MH, Henderson DC, Gotch FM, Gazzard BG, Kelleher P. Steel A, et al. Among authors: gotch fm. HIV Med. 2008 Feb;9(2):118-25. doi: 10.1111/j.1468-1293.2007.00528.x. HIV Med. 2008. PMID: 18257774 Free article.

7

Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals.

Gregson JN, Steel A, Bower M, Gazzard BG, Gotch FM, Goodier MR. Gregson JN, et al. AIDS. 2009 Jan 2;23(1):29-34. doi: 10.1097/QAD.0b013e3283199780. AIDS. 2009. PMID: 19050383

8

Vaccines for the control of HIV/AIDS.

Gotch F, Rutebemberwa A, Jones G, Imami N, Gilmour J, Kaleebu P, Whitworth J. Gotch F, et al. Trop Med Int Health. 2000 Jul;5(7):A16-21. doi: 10.1046/j.1365-3156.2000.00593.x. Trop Med Int Health. 2000. PMID: 10964278 Free article. Review.

9

Alterations in blood leucocyte adhesion molecule profiles in HIV-1 infection.

Hayes PJ, Miao YM, Gotch FM, Gazzard BG. Hayes PJ, et al. Among authors: gotch fm. Clin Exp Immunol. 1999 Aug;117(2):331-4. doi: 10.1046/j.1365-2249.1999.00983.x. Clin Exp Immunol. 1999. PMID: 10444267 Free PMC article.

10

Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals.

Mela CM, Steel A, Lindsay J, Gazzard BG, Gotch FM, Goodier MR. Mela CM, et al. AIDS. 2007 Oct 18;21(16):2177-82. doi: 10.1097/QAD.0b013e3282f08b72. AIDS. 2007. PMID: 18090044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters